We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Encourages Veru to Submit EUA Application for COVID-19 Therapy
FDA Encourages Veru to Submit EUA Application for COVID-19 Therapy
In the wake of strongly positive data and an FDA go-ahead, Veru will seek an Emergency Use Authorization (EUA) for sabizabulin, its investigational COVID-19 therapy.